NASDAQ:BTAI

Bioxcel Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy BTAI

*Your capital is at risk

$1.16

-0.0300 (-2.52%)

At Close: Jun 03, 2026

BioXcel Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 35.51. In total, the insiders bought 837.19K and sold 39.67K BTAI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	35.51
● Buy	837.19K shares
● Sell	39.67K shares
96% Buy Activity Moderate Negative Correlation
Buy Signal Medium Confidence Jun 01, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 35.51. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (96% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 20, 2026 Sell	Common Stock S-Sale	Mehta Vimal CEO And President	CEO / President	19 419 Value: $21.1K
May 20, 2026 Sell	Common Stock S-Sale	Rodriguez Javier See Remarks	Officer	6 560 Value: $7K
May 20, 2026 Sell	Common Stock S-Sale	Yocca Frank Chief Scientific Officer	Officer	6 845 Value: $7K
May 20, 2026 Sell	Common Stock S-Sale	Steinhart Richard I Chief Financial Officer	C-Suite Officer	6 845 Value: $7K
May 04, 2026 Buy	Common Stock M-Exempt	Mehta Vimal CEO And President	CEO / President	49 758 Value: $62.7K
May 04, 2026 Buy	Common Stock M-Exempt	Steinhart Richard I Chief Financial Officer	C-Suite Officer	17 500 Value: $22.1K
May 04, 2026 Buy	Restricted Stock Units M-Exempt	Steinhart Richard I Chief Financial Officer	C-Suite Officer	17 500 Value: $22.1K
May 04, 2026 Buy	Common Stock M-Exempt	Rodriguez Javier See Remarks	Officer	17 500 Value: $22.1K
May 04, 2026 Buy	Restricted Stock Units M-Exempt	Yocca Frank Chief Scientific Officer	Officer	17 500 Value: $22.1K
May 04, 2026 Buy	Common Stock M-Exempt	Yocca Frank Chief Scientific Officer	Officer	17 500 Value: $22.1K
May 04, 2026 Buy	Restricted Stock Units M-Exempt	Rodriguez Javier See Remarks	Officer	17 500 Value: $22.1K
May 04, 2026 Buy	Restricted Stock Units M-Exempt	Mehta Vimal CEO And President	CEO / President	49 758 Value: $62.7K
May 01, 2026 Buy	Restricted Stock Units M-Exempt	Rodriguez Javier See Remarks	Officer	9 000 Value: $10.8K
May 01, 2026 Buy	Common Stock M-Exempt	Rodriguez Javier See Remarks	Officer	9 000 Value: $10.8K
May 01, 2026 Buy	Common Stock M-Exempt	Mehta Vimal CEO And President	CEO / President	18 000 Value: $21.6K
May 01, 2026 Buy	Restricted Stock Units M-Exempt	Mehta Vimal CEO And President	CEO / President	18 000 Value: $21.6K
May 01, 2026 Buy	Common Stock M-Exempt	Steinhart Richard I Chief Financial Officer	C-Suite Officer	9 000 Value: $10.8K
May 01, 2026 Buy	Restricted Stock Units M-Exempt	Steinhart Richard I Chief Financial Officer	C-Suite Officer	9 000 Value: $10.8K
May 01, 2026 Buy	Common Stock M-Exempt	Yocca Frank Chief Scientific Officer	Officer	9 000 Value: $10.8K
May 01, 2026 Buy	Restricted Stock Units M-Exempt	Yocca Frank Chief Scientific Officer	Officer	9 000 Value: $10.8K
Mar 15, 2026 Buy	Restricted Stock Units M-Exempt	Yocca Frank Chief Scientific Officer	Officer	35 Value: $41
Mar 15, 2026 Buy	Common Stock M-Exempt	Yocca Frank Chief Scientific Officer	Officer	35 Value: $41
Mar 15, 2026 Buy	Restricted Stock Units M-Exempt	Rodriguez Javier See Remarks	Officer	35 Value: $41
Mar 15, 2026 Buy	Common Stock M-Exempt	Rodriguez Javier See Remarks	Officer	35 Value: $41
Mar 15, 2026 Buy	Common Stock M-Exempt	Mehta Vimal CEO And President	CEO / President	219 Value: $254

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIOXCEL THERAPEUTICS INC.

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI...

Read Full Profile Here